Predictors of ineffective cough during a chest infection in patients with stable amyotrophic lateral sclerosis.

RATIONALE In patients with neuromuscular diseases, a chest infection is associated with a reduction in respiratory muscle function that may result in decreased cough effectiveness. OBJECTIVES To determine if a clinical or functional parameter in patients with amyotrophic lateral sclerosis (ALS) in a stable condition could predict spontaneous cough ineffectiveness during a respiratory tract infection. METHODS Forty consecutive patients with ALS referred to our Respiratory Care Unit were studied during a one-year follow-up. MEASUREMENTS AND MAIN RESULTS FEV(1), FVC, FEV(1)/FVC, peak cough flow (PCF), peak velocity time (PVT), maximum inspiratory and expiratory pressures, and bulbar dysfunction evaluation using the Norris scale bulbar subscore (NBS). A total of 26 patients (65%) had spontaneous cough ineffectiveness during a respiratory tract infection. The best variables to predict nonassisted cough during a respiratory tract infection were NBS (p < 0.01) with a cutoff point of 29 (sensitivity, 0.89; specificity, 0.90; positive predicted value, 0.88; negative predictive value, 0.87), PCF (p < 0.001) with a cutoff point of 4.25 L/s (sensitivity, 0.74; specificity, 0.85; positive predictive value, 0.71; negative predictive value, 0.85), and PCF/PVT (p < 0.001) with a cutoff point of 28.88 L/s(2) (sensitivity, 0.77; specificity, 0.96; positive predictive value, 0.91; negative predictive value, 0.89). CONCLUSIONS In patients with stable ALS, bulbar dysfunction (NBS < 29), PCF (< 4.25 L/s), and PCF/PVT (< 28.88 L/s(2)) could predict the risk of ineffective spontaneous cough during a respiratory tract infection.

[1]  J E Cotes,et al.  Lung volumes and forced ventilatory flows , 1993, European Respiratory Journal.

[2]  J E Cotes,et al.  Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. , 1993, The European respiratory journal. Supplement.

[3]  J. Bach.  Amyotrophic lateral sclerosis: prolongation of life by noninvasive respiratory AIDS. , 2002, Chest.

[4]  J. Sancho,et al.  Appropriate management of respiratory problems is of utmost importance in the treatment of patients with amyotrophic lateral sclerosis. , 2005, Chest.

[5]  M. Green,et al.  Respiratory muscle weakness during upper respiratory tract infections. , 1988, The American review of respiratory disease.

[6]  M. Chaudri,et al.  Relationship between supramaximal flow during cough and mortality in motor neurone disease , 2002, European Respiratory Journal.

[7]  Julio Marín,et al.  Comparison of Peak Cough Flows Measured by Pneumotachograph and a Portable Peak Flow Meter , 2004, American journal of physical medicine & rehabilitation.

[8]  J. Escarrabill,et al.  Survival in amyotrophic lateral sclerosis with home mechanical ventilation: the impact of systematic respiratory assessment and bulbar involvement. , 2005, Chest.

[9]  M. Polkey,et al.  Expiratory muscle function in amyotrophic lateral sclerosis. , 1998, American journal of respiratory and critical care medicine.

[10]  H. Levison,et al.  Cough capacity in patients with muscular dystrophy. , 1988, Chest.

[11]  J. Bach,et al.  Criteria for extubation and tracheostomy tube removal for patients with ventilatory failure. A different approach to weaning. , 1996, Chest.

[12]  A. Dimarco,et al.  Effect of upper respiratory tract infection in patients with neuromuscular disease. , 1997, American journal of respiratory and critical care medicine.

[13]  R. Light.  Pulmonary pathophysiology of pneumococcal pneumonia. , 1999, Seminars in respiratory infections.

[14]  P. Shaw,et al.  Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial , 2006, The Lancet Neurology.

[15]  G. Diette,et al.  Hospitalization in amyotrophic lateral sclerosis , 2001, Neurology.

[16]  P. Andersen,et al.  EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives , 2005, European journal of neurology.

[17]  L. F. Black,et al.  Maximal respiratory pressures: normal values and relationship to age and sex. , 2015 .

[18]  J. Bach,et al.  Amyotrophic lateral sclerosis: predictors for prolongation of life by noninvasive respiratory aids. , 1995, Archives of physical medicine and rehabilitation.

[19]  M. King,et al.  Clearance of mucus by simulated cough. , 1985, Journal of applied physiology.

[20]  J. Sancho,et al.  Alternatives to Endotracheal Intubation for Patients with Neuromuscular Diseases , 2005, American journal of physical medicine & rehabilitation.

[21]  M. Swash,et al.  El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis , 2000, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[22]  F. Mccool,et al.  Global physiology and pathophysiology of cough: ACCP evidence-based clinical practice guidelines. , 2006, Chest.

[23]  J. Bach,et al.  Prevention of pulmonary morbidity for patients with neuromuscular disease. , 2000, Chest.

[24]  J. Bach,et al.  Neuromuscular ventilatory insufficiency: effect of home mechanical ventilator use v oxygen therapy on pneumonia and hospitalization rates. , 1998, American journal of physical medicine & rehabilitation.

[25]  M. Pistolesi,et al.  Coughing in laryngectomized patients. , 1999, American journal of respiratory and critical care medicine.

[26]  F. Norris,et al.  The administration of guanidine in amyotrophic lateral sclerosis , 1974, Neurology.

[27]  J. Sancho,et al.  Efficacy of mechanical insufflation-exsufflation in medically stable patients with amyotrophic lateral sclerosis. , 2004, Chest.

[28]  W. Kinnear,et al.  The effect of a mechanical glottis on peak expiratory flow rate and time to peak flow during a peak expiratory flow manoeuvre: A study in normal subjects and patients with motor neurone disease , 2004, Anaesthesia.

[29]  J. Bach,et al.  Prevention of pulmonary morbidity for patients with Duchenne muscular dystrophy. , 1997, Chest.

[30]  C. M. Wiles,et al.  Respiratory complications related to bulbar dysfunction in motor neuron disease , 2001, Acta neurologica Scandinavica.

[31]  A. Aitkenhead,et al.  Relationship between expired lung volume, peak flow rate and peak velocity time during a voluntary cough manoeuvre. , 1994, British journal of anaesthesia.